- Active not recruitingPHASE1
A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
This study is looking at a new prostate cancer drug, JNJ-56021927, alongside existing treatments like abiraterone acetate and prednisone. Researchers want to see if these drugs work well together, check for side effects, and find the best doses for future studies in men with advanced prostate cancer.
For: Prostatic Neoplasms · Metastatic Castration-Resistant Prostate CancerUnited States · Canada · Netherlands - Ongoing, recruitingTherapeutic exploratory (Phase II)
A feasibility trial investigating inductive Apalutamide therapy combined with radical prostatectomy in patients with locally advanced T4 high risk prostate cancer
This study looks at a new drug, JNJ-56021927, for men with aggressive prostate cancer that hasn't spread. It aims to see if treating with this drug before surgery can help shrink the cancer and make surgery more successful, measuring how many men become able to have their prostate removed.
For: Patients with locally advanced T4 high risk prostate cancerGermany